Abstract
BACKGROUND AND PURPOSE: Based on artificial intelligence (AI), 3D angiography (3DA) is a novel postprocessing algorithm for "DSA-like" 3D imaging of cerebral vasculature. Because 3DA requires neither mask runs nor digital subtraction as the current standard 3D-DSA does, it has the potential to cut the patient dose by 50%. The object was to evaluate 3DA's diagnostic value for visualization of intracranial artery stenoses (IAS) compared to 3D-DSA. MATERIALS AND METHODS: 3D-DSA datasets of IAS (n(IAS) = 10) were postprocessed using conventional and prototype software (Siemens Healthineers AG, Erlangen, Germany). Matching reconstructions were assessed by two experienced neuroradiologists in consensus reading, considering image quality (IQ), vessel diameters (VD(1/2)), vessel-geometry index (VGI = VD(1)/VD(2)), and specific qualitative/quantitative parameters of IAS (e.g., location, visual IAS grading [low-/medium-/high-grade] and intra-/poststenotic diameters [d(intra-/poststenotic) in mm]). Using the NASCET criteria, the percentual degree of luminal restriction was calculated. RESULTS: In total, 20 angiographic 3D volumes (n(3DA) = 10; n(3D-DSA) = 10) were successfully reconstructed with equivalent IQ. Assessment of the vessel geometry in 3DA datasets did not differ significantly from 3D-DSA (VD(1): r = 0.994, p = 0.0001; VD(2):r = 0.994, p = 0.0001; VGI: r = 0.899, p = 0.0001). Qualitative analysis of IAS location (3DA/3D-DSA:n(ICA/C4) = 1, n(ICA/C7) = 1, n(MCA/M1) = 4, n(VA/V4) = 2, n(BA) = 2) and the visual IAS grading (3DA/3D-DSA:n(low-grade) = 3, n(medium-grade) = 5, n(high-grade) = 2) revealed identical results for 3DA and 3D-DSA, respectively. Quantitative IAS assessment showed a strong correlation regarding intra-/poststenotic diameters (r(dintrastenotic) = 0.995, p(dintrastenotic) = 0.0001; r(dpoststenotic) = 0.995, p(dpoststenotic) = 0.0001) and the percentual degree of luminal restriction (r(NASCET 3DA) = 0.981; p(NASCET 3DA) = 0.0001). CONCLUSIONS: The AI-based 3DA is a resilient algorithm for the visualization of IAS and shows comparable results to 3D-DSA. Hence, 3DA is a promising new method that allows a considerable patient-dose reduction, and its clinical implementation would be highly desirable.